RT Journal Article
SR Electronic
T1 Deep-learning-based Prediction of Late Age-Related Macular Degeneration Progression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006171
DO 10.1101/19006171
A1 Yan, Qi
A1 Weeks, Daniel E.
A1 Xin, Hongyi
A1 Huang, Heng
A1 Swaroop, Anand
A1 Chew, Emily Y.
A1 Ding, Ying
A1 Chen, Wei
YR 2020
UL http://medrxiv.org/content/early/2020/02/18/19006171.abstract
AB Both genetic and environmental factors influence the etiology of age-related macular degeneration (AMD), a leading cause of blindness. AMD severity is primarily measured by fundus images and recently developed machine learning methods can successfully predict AMD progression using image data. However, none of these methods have utilized both genetic and image data for predicting AMD progression. Here we jointly used genotypes and fundus images to predict an eye as having progressed to late AMD with a modified deep convolutional neural network (CNN). In total, we used 31,262 fundus images and 52 AMD-associated genetic variants from 1,351 subjects from the Age-Related Eye Disease Study (AREDS) with disease severity phenotypes and fundus images available at baseline and follow-up visits over a period of 12 years. Our results showed that fundus images coupled with genotypes could predict late AMD progression with an averaged area under the curve (AUC) value of 0.85 (95%CI: 0.83-0.86). The results using fundus images alone showed an averaged AUC of 0.81 (95%CI: 0.80-0.83). We implemented our model in a cloud-based application for individual risk assessment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll the phenotype data and fundus images of AREDS participants required are available from dbGap (accession: phs000001.v3.p1). The genotype data on AREDS subjects has been reported earlier 11 and is available from dbGap (accession phs001039.v1.p1). The UK Biobank test dataset was obtained from UK Biobank (application number 43252).https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000001.v3.p1https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001039.v1.p1